|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Descriptive Information Fields | |||||
| Brief Title † | African-American Heart Failure Trial | ||||
| Official Title † | |||||
| Brief Summary | A placebo-controlled trial of BiDil added to standard therapy in African-American patients with heart failure. |
||||
| Detailed Description | The overall objective is confirmation of BiDil’s Safety and Efficacy in African-American (AFA) Patients with Moderate to Severe Symptomatic Heart Failure. |
||||
| Study Phase | Phase IV | ||||
| Study Type † | Interventional | ||||
| Study Design † | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study | ||||
| Primary Outcome Measure † | |||||
| Secondary Outcome Measure † | |||||
| Condition † | Congestive Heart Failure | ||||
| Intervention † | Drug: BiDil | ||||
| MEDLINE PMIDs | |||||
| Links | |||||
| Recruitment Information Fields | |||||
| Recruitment Status † | Completed | ||||
| Enrollment † | 1100 | ||||
| Start Date † | May 2001 | ||||
| Completion Date | August 2004 | ||||
| Eligibility Criteria † |
|
||||
| Gender | Both | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts †† | |||||
| Location Countries † | United States | ||||
| Administrative Information Fields | |||||
| NCT ID † | NCT00047775 | ||||
| Organization ID | A-HeFT | ||||
| Secondary IDs †† | |||||
| Study Sponsor † | Nitromed | ||||
| Collaborators †† | |||||
| Investigators † |
|
||||
| Information Provided By | Nitromed | ||||
| Verification Date | October 2004 | ||||
| First Received Date † | October 18, 2002 | ||||
| Last Updated Date | June 23, 2005 | ||||